Drawing for TOXNET

USPTO serial 79292872

TOXNET

Reviewed by CopyMark Law Group

Reg. 6726684Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
STURMAN, MELISSA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TOXNET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JEFFREY L. VAN HOOSEAR

Salima Merani Ph.D. Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016Books in the field of medicine and aesthetic dermatology; printed matter, namely, newsletters, magazines, pamphlets, and written articles in the field of medicine and aesthetics dermatology; printed instructional and teaching material in the field of medicine and aesthetic dermatology; copy paper and stationery; printed periodicals in the field of medicine and aesthetic dermatology; magazines featuring medicine and aesthetic dermatology; newspapers; all the foregoing excluding the fields of toxicology, toxic substances and hazardous wasteACTIVE
035Online advertising services for others; advertising services in the field of medicine, cosmetic surgery, beauty, and aesthetic dermatology; advertising services for goods and services via websites; advertising, namely, online-advertisements via a global computer network; all the foregoing excluding the fields of toxicology, toxic substances and hazardous wasteACTIVE
041Training seminars in the field of pharmaceuticals; medical training and teaching; vocational education services in the field of medicine and aesthetic dermatology; vocational education in the field of medicine for medical personnel; vocational education services in the field of cosmetics; providing online, non-downloadable publications in the nature of newsletters, magazines, pamphlets, specialized journals, and articles in the field of medicine and aesthetic dermatology; providing non-downloadable electronic publications in the nature of blogs and articles in the field of medicine and aesthetic dermatology; arranging, conducting, and organization of educational seminars, classes, workshops, and colloquiums in the field of aesthetic dermatology; organization of educational seminars and classes in the field of medicine; publishing and issuing of scientific papers in the field of medicine; publication of printed matter, books, and magazines; providing online non-downloadable electronic publications in the nature of newsletters, magazines, pamphlets, and articles in the field of medicine, cosmetic surgery, beauty, and aesthetic dermatology; all the foregoing excluding the fields of toxicology, toxic substances and hazardous wasteACTIVE
042Scientific research in the medical field; medical research and development of pharmaceuticals and cosmetics; medical research; medical and pharmaceutical research services; pharmaceutical research and development; scientific research and development; computer technological services, namely, providing a website featuring an on-line, non-downloadable, software application for connecting users to databases which provide scientific and technical information on aesthetic dermatology and medicine, excluding databases in the fields of toxicology, toxic substances and hazardous waste; all the foregoing excluding the fields of toxicology, toxic substances and hazardous wasteACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 2, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 7, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 7, 2022FIMPFINAL DISPOSITION PROCESSED
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 7, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2022GPNXNOTIFICATION PROCESSED BY IB
Feb 16, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 16, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 9, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 9, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 25, 2022EXPTEXPARTE APPEAL TERMINATED
Jan 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2022XAECEXAMINER'S AMENDMENT ENTERED
Jan 25, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 25, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Jan 25, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Dec 3, 2021DOCKASSIGNED TO EXAMINER
Nov 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2021ALIEASSIGNED TO LIE
Nov 8, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 8, 2021EXPIEX PARTE APPEAL-INSTITUTED
Nov 8, 2021JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 8, 2021EXAFEXPARTE APPEAL RECEIVED AT TTAB
May 13, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
May 13, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 13, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2021DOCKASSIGNED TO EXAMINER
Mar 31, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 31, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2020RFNTREFUSAL PROCESSED BY IB
Oct 3, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 3, 2020RFRRREFUSAL PROCESSED BY MPU
Sep 15, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 15, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Sep 14, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2020DOCKASSIGNED TO EXAMINER
Sep 11, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 3, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance